 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 11/08/2019 |
$0.50 |
$0.50 |
$0.48 |
$0.49 |
121.80K | | 11/11/2019 |
$0.49 |
$0.53 |
$0.49 |
$0.50 |
302.70K | | 11/12/2019 |
$0.49 |
$0.51 |
$0.49 |
$0.51 |
167.30K | | 11/13/2019 |
$0.52 |
$0.52 |
$0.49 |
$0.49 |
228.90K | | 11/14/2019 |
$0.50 |
$0.50 |
$0.45 |
$0.47 |
207.50K |
|
|
| Hemispherx Biopharma is an immuno-pharma company, focused on the research and development of therapeutics to treat several types of cancers, as well as immune-deficiency disorders. Co. has a foundation of laboratory, pre-clinical and clinical data with respect to the development of nucleic acids and natural interferon to enhance the natural antiviral defense system of the human body and to aid the development of therapeutic products for the treatment of certain cancers and chronic diseases. Co.'s products include Ampligen®, a drug of macromolecular ribonucleic acid molecules, and Alferon N Injection®, a drug also known as a chemical entity that contains an active moiety | |
|
AIM ImmunoTech (AIM) has the following price history information. Looking back at AIM historical stock prices for the last five trading days, on November 08, 2019, AIM opened at $0.50, traded as high as $0.50 and as low as $0.48, and closed at $0.49. Trading volume was a total of 121.80K shares. On November 11, 2019, AIM opened at $0.49, traded as high as $0.53 and as low as $0.49, and closed at $0.50. Trading volume was a total of 302.70K shares. On November 12, 2019, AIM opened at $0.49, traded as high as $0.51 and as low as $0.49, and closed at $0.51. Trading volume was a total of 167.30K shares. On November 13, 2019, AIM opened at $0.52, traded as high as $0.52 and as low as $0.49, and closed at $0.49. Trading volume was a total of 228.90K shares. On November 14, 2019, AIM opened at $0.50, traded as high as $0.50 and as low as $0.45, and closed at $0.47. Trading volume was a total of 207.50K shares.
AIM Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into AIM ImmunoTech shares, starting with a $10,000 purchase of AIM, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
11/16/2009 |
|
| End date: |
11/14/2019 |
|
| Start price/share: |
$1.08 |
|
| End price/share: |
$0.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-56.48% |
|
| Average Annual Total Return: |
-7.98% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,353.34 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 11/08/2019 | $0.49 | | 11/11/2019 | $0.50 | | 11/12/2019 | $0.51 | | 11/13/2019 | $0.49 | | 11/14/2019 | $0.47 |
|
|
